Logo image of LOVE.CA

CANNARA BIOTECH INC (LOVE.CA) Stock Fundamental Analysis

TSX-V:LOVE - TSX Venture Exchange - CA13765U2002 - Common Stock - Currency: CAD

1.34  +0.04 (+3.08%)

Fundamental Rating

4

LOVE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 4 industry peers in the Personal Care Products industry. The financial health of LOVE is average, but there are quite some concerns on its profitability. LOVE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

LOVE had positive earnings in the past year.
In the past year LOVE had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: LOVE reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: LOVE reported negative operating cash flow in multiple years.
LOVE.CA Yearly Net Income VS EBIT VS OCF VS FCFLOVE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

LOVE's Return On Assets of 8.30% is amongst the best of the industry. LOVE outperforms 100.00% of its industry peers.
LOVE's Return On Equity of 14.22% is amongst the best of the industry. LOVE outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 8.3%
ROE 14.22%
ROIC N/A
ROA(3y)3.63%
ROA(5y)-2.7%
ROE(3y)6.49%
ROE(5y)-3.09%
ROIC(3y)N/A
ROIC(5y)N/A
LOVE.CA Yearly ROA, ROE, ROICLOVE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

LOVE's Profit Margin of 14.16% is amongst the best of the industry. LOVE outperforms 100.00% of its industry peers.
LOVE has a Gross Margin of 9.96%. This is in the lower half of the industry: LOVE underperforms 75.00% of its industry peers.
LOVE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 14.16%
GM 9.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.07%
GM growth 5Y-41.26%
LOVE.CA Yearly Profit, Operating, Gross MarginsLOVE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

5

2. Health

2.1 Basic Checks

LOVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LOVE has been reduced compared to 1 year ago.
The number of shares outstanding for LOVE has been increased compared to 5 years ago.
LOVE has a better debt/assets ratio than last year.
LOVE.CA Yearly Shares OutstandingLOVE.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LOVE.CA Yearly Total Debt VS Total AssetsLOVE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

LOVE has an Altman-Z score of 1.65. This is a bad value and indicates that LOVE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.65, LOVE is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
The Debt to FCF ratio of LOVE is 8.39, which is on the high side as it means it would take LOVE, 8.39 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of LOVE (8.39) is better than 75.00% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that LOVE is not too dependend on debt financing.
LOVE has a better Debt to Equity ratio (0.43) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 8.39
Altman-Z 1.65
ROIC/WACCN/A
WACC6.82%
LOVE.CA Yearly LT Debt VS Equity VS FCFLOVE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

LOVE has a Current Ratio of 2.35. This indicates that LOVE is financially healthy and has no problem in meeting its short term obligations.
LOVE's Current ratio of 2.35 is fine compared to the rest of the industry. LOVE outperforms 75.00% of its industry peers.
LOVE has a Quick Ratio of 2.35. This is a bad value and indicates that LOVE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of LOVE (0.93) is better than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 0.93
LOVE.CA Yearly Current Assets VS Current LiabilitesLOVE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 110.22% over the past year.
The Revenue has grown by 28.97% in the past year. This is a very strong growth!
LOVE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 108.26% yearly.
EPS 1Y (TTM)110.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%193.73%
Revenue 1Y (TTM)28.97%
Revenue growth 3Y68.19%
Revenue growth 5Y108.26%
Sales Q2Q%35.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LOVE.CA Yearly Revenue VS EstimatesLOVE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.93, which indicates a very decent valuation of LOVE.
100.00% of the companies in the same industry are more expensive than LOVE, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of LOVE to the average of the S&P500 Index (24.12), we can say LOVE is valued rather cheaply.
Industry RankSector Rank
PE 8.93
Fwd PE N/A
LOVE.CA Price Earnings VS Forward Price EarningsLOVE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

LOVE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LOVE is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.05
EV/EBITDA N/A
LOVE.CA Per share dataLOVE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LOVE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANNARA BIOTECH INC

TSX-V:LOVE (5/8/2025, 7:00:00 PM)

1.34

+0.04 (+3.08%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)04-28 2025-04-28
Earnings (Next)07-25 2025-07-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners27.69%
Ins Owner ChangeN/A
Market Cap122.52M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.93
Fwd PE N/A
P/S 1.29
P/FCF 21.05
P/OCF 10.86
P/B 1.3
P/tB 1.3
EV/EBITDA N/A
EPS(TTM)0.15
EY11.19%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY4.75%
OCF(TTM)0.12
OCFY9.21%
SpS1.04
BVpS1.03
TBVpS1.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.3%
ROE 14.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 14.16%
GM 9.96%
FCFM 6.15%
ROA(3y)3.63%
ROA(5y)-2.7%
ROE(3y)6.49%
ROE(5y)-3.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.07%
GM growth 5Y-41.26%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 8.39
Debt/EBITDA N/A
Cap/Depr 84.34%
Cap/Sales 5.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 43.44%
Current Ratio 2.35
Quick Ratio 0.93
Altman-Z 1.65
F-Score5
WACC6.82%
ROIC/WACCN/A
Cap/Depr(3y)228.25%
Cap/Depr(5y)410.31%
Cap/Sales(3y)22.24%
Cap/Sales(5y)120%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%193.73%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.97%
Revenue growth 3Y68.19%
Revenue growth 5Y108.26%
Sales Q2Q%35.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y132.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y334.7%
OCF growth 3YN/A
OCF growth 5YN/A